| Net Cash Provided by (Used in) Operating Activities |
$123,717 |
USD |
-31% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$169,965 |
USD |
125% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$60,471 |
USD |
21% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
220,000,000 |
shares |
0% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares, Issued |
2,548,000 |
shares |
0% |
Q1 2025 |
Q1 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$14,223 |
USD |
85% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$850 |
USD |
-27% |
Q1 2025 |
Q1 2025 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q1 2025 |
Q1 2025 |
| Preferred Stock, Shares Authorized |
1,000,000 |
shares |
0% |
Q1 2025 |
Q1 2025 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q1 2025 |
Q1 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q1 2025 |
Q1 2025 |